Disposition of flavonoids via recycling: Direct biliary excretion of enterically or extrahepatically derived flavonoid glucuronides.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Molecular Nutrition & Food Research

• Publication date

  2016-04-13

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1002/mnfr.201500692PMID 26843117PMCID PMC5358014
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Triple Recycling Processes Impact Systemic and Local Bioavailability of Orally Administered Flavonoids

  2015cited by this paper
• Impaired Hepatic Uptake by Organic Anion-Transporting Polypeptides Is Associated with Hyperbilirubinemia and Hypercholanemia in Atp11c Mutant Mice

  2015cited by this paper
• Determination of pharmacokinetics of chrysin and its conjugates in wild-type FVB and Bcrp1 knockout mice using a validated LC-MS/MS method.

  2015cited by this paper
• Hepatic Disposition of Gemfibrozil and Its Major Metabolite Gemfibrozil 1-O-β-Glucuronide.

  2015cited by this paper
• Simultaneous Determination of Sulfation and Glucuronidation of Flavones in FVB Mouse Intestine in Vitro and in Vivo

  2013cited by this paper
• Transport and biological activities of bile acids.

  2013cited by this paper
• Organic anion transporting polypeptides OATP1B1 and OATP1B3 and their genetic variants influence the pharmacokinetics and pharmacodynamics of raloxifene

  2012cited by this paper
• Mechanistic Studies on the Absorption and Disposition of Scutellarin in Humans: Selective OATP2B1-Mediated Hepatic Uptake Is a Likely Key Determinant for Its Unique Pharmacokinetic Characteristics

  2012influential reference
• A novel local recycling mechanism that enhances enteric bioavailability of flavonoids and prolongs their residence time in the gut.

  2012cited by this paper
• UDP-Glucuronosyltransferase (UGT) 1A9-Overexpressing HeLa Cells Is an Appropriate Tool to Delineate the Kinetic Interplay between Breast Cancer Resistance Protein (BRCP) and UGT and to Rapidly Identify the Glucuronide Substrates of BCRP

  2012cited by this paper
• Three-Dimensional Quantitative Structure-Activity Relationship Studies on UGT1A9-Mediated 3-O-Glucuronidation of Natural Flavonols Using a Pharmacophore-Based Comparative Molecular Field Analysis Model

  2011cited by this paper
• Regioselective Glucuronidation of Flavonols by Six Human UGT1A Isoforms

  2011cited by this paper
• Uridine diphosphate glucuronosyltransferase isoform-dependent regiospecificity of glucuronidation of flavonoids.

  2011cited by this paper
• Evaluation of 3,3',4'-trihydroxyflavone and 3,6,4'-trihydroxyflavone (4'-O-glucuronidation) as the in vitro functional markers for hepatic UGT1A1.

  2011cited by this paper
• The bioavailability of apigenin-7-glucoside is influenced by human intestinal microbiota in rats.

  2009cited by this paper
• Disposition of Flavonoids via Enteric Recycling: UDP-Glucuronosyltransferase (UGT) 1As Deficiency in Gunn Rats Is Compensated by Increases in UGT2Bs Activities

  2009cited by this paper
• Uptake of glucuronides into isolated hepatocytes and their effects on glucuronide and sulphate conjugation.

  2009cited by this paper
• Disposition of ezetimibe is influenced by polymorphisms of the hepatic uptake carrier OATP1B1

  2008cited by this paper
• Commentary: bioavailability of flavonoids and polyphenols: call to arms.

  2007cited by this paper
• Biosynthesis of bile acids in mammalian liver

  2006cited by this paper
• Disposition of Flavonoids via Enteric Recycling: Structural Effects and Lack of Correlations between in Vitro and in Situ Metabolic Properties

  2006influential reference
• The bioavailability of polyphenols is highly governed by the capacity of the intestine and of the liver to secrete conjugated metabolites

  2006cited by this paper
• Pharmacokinetics and bioavailability of the isoflavone biochanin A in rats

  2006cited by this paper
• Factors affecting the bioavailability of soy isoflavones in humans.

  2006cited by this paper
• PHARMACOKINETICS AND METABOLISM OF APIGENIN IN FEMALE AND MALE RATS AFTER A SINGLE ORAL ADMINISTRATION

  2005cited by this paper
• DISPOSITION OF FLAVONOIDS VIA RECYCLING: COMPARISON OF INTESTINAL VERSUS HEPATIC DISPOSITION

  2005influential reference
• Flavonoid compounds in maintenance of prostate health and prevention and treatment of cancer

  2005cited by this paper
• Coupling of conjugating enzymes and efflux transporters: impact on bioavailability and drug interactions.

  2005cited by this paper
• Health Benefits of Soy Isoflavonoids and Strategies for Enhancement: A Review

  2004cited by this paper
• Disposition of Flavonoids via Enteric Recycling: Enzyme-Transporter Coupling Affects Metabolism of Biochanin A and Formononetin and Excretion of Their Phase II Conjugates

  2004cited by this paper
• Interactions of phytoestrogens with estrogen receptors alpha and beta (III). Estrogenic activities of soy isoflavone aglycones and their metabolites isolated from human urine.

  2004cited by this paper
• Interactions of Phytoestrogens with Estrogen Receptors α and β (III). Estrogenic Activities of Soy Isoflavone Aglycones and Their Metabolites Isolated from Human Urine

  2004cited by this paper
• Function of uptake transporters for taurocholate and estradiol 17beta-D-glucuronide in cryopreserved human hepatocytes.

  2003cited by this paper
• Metabolism of isoflavones and lignans by the gut microflora: a study in germ-free and human flora associated rats.

  2003cited by this paper
• Metabolism of Flavonoids via Enteric Recycling: Role of Intestinal Disposition

  2003influential reference
• Metabolism of quercetin-7- and quercetin-3-glucuronides by an in vitro hepatic model: the role of human beta-glucuronidase, sulfotransferase, catechol-O-methyltransferase and multi-resistant protein 2 (MRP2) in flavonoid metabolism.

  2003cited by this paper
• Enterohepatic Circulation

  2002cited by this paper
• Absorption and metabolism of flavonoids in the caco-2 cell culture model and a perused rat intestinal model.

  2002cited by this paper
• Dietary flavonoids: bioavailability, metabolic effects, and safety.

  2002cited by this paper
• Disposition and metabolism of the flavonoid chrysin in normal volunteers.

  2001cited by this paper
• Catechin is metabolized by both the small intestine and liver of rats.

  2001cited by this paper
• Isoflavones from tofu are absorbed and metabolized in the isolated rat small intestine.

  2000cited by this paper
• Part of quercetin absorbed in the small intestine is conjugated and further secreted in the intestinal lumen.

  1999cited by this paper
• Contribution of sodium taurocholate co-transporting polypeptide to the uptake of its possible substrates into rat hepatocytes.

  1998cited by this paper
• Bioavailability and health effects of dietary flavonols in man.

  1998cited by this paper
• Absorption, Distribution, and Elimination of Tea Polyphenols in Rats

  1997cited by this paper
• Carrier-mediated active transport of the glucuronide and sulfate of 6-hydroxy-5,7-dimethyl-2-methylamino-4-(3-pyridylmethyl) benzothiazole (E3040) into rat liver: quantitative comparison of permeability in isolated hepatocytes, perfused liver and liver in vivo.

  1997cited by this paper
• Absorption, distribution, elimination of tea polyphenols in rats.

  1997cited by this paper
• Physiological Parameters in Laboratory Animals and Humans

  1993cited by this paper
• Cytotoxic effect and uptake mechanism by isolated rat hepatocytes of lithocholate and its glucuronide and sulfate.

  1991cited by this paper
• Mirex exposure inhibits the uptake of estradiol-17 beta(beta-D-glucuronide), taurocholate, and L-alanine into isolated rat hepatocytes.

  1990cited by this paper
• Determination of hepatic blood flow in the rat using sequential infusions of indocyanine green or galactose.

  1990cited by this paper
• Mirex exposure inhibits the uptake of estradiol-17β(β-d-glucuronide), taurocholate, and l-alanine into isolated rat hepatocytes

  1990cited by this paper
• Membrane-limited hepatic transport of the conjugative metabolites of 4-methylumbelliferone in rats.

  1988cited by this paper
• Multiple carriers for uptake of [3H]estradiol-17 beta(beta-D-glucuronide) in isolated rat hepatocytes.

  1987cited by this paper
• Characterization of uptake of steroid glucuronides into isolated male and female rat hepatocytes.

  1984cited by this paper
• Uptake of iopanoic acid and its glucuronide conjugate by rat hepatocytes in primary culture.

  1983cited by this paper
• Drug metabolism and disposition : the biological fate of chemicals.

  1973cited by this paper

• Flavonoids.

  2026cites this paper
• Discovering Skin Anti-Aging Potentials of the Most Abundant Flavone Phytochemical Compound Reported in Siam Violet Pearl, a Medicinal Plant from Thailand by In Silico and In Vitro Assessments

  2025cites this paper
• Pharmacokinetics of 7,8-dihydroxyflavone in neonatal mice with hypoxia-ischemia related brain injury

  2025cites this paper
• Studying the effects of Saposhnikoviae Radix on the pharmacokinetic profiles of 10 bioactive compounds originating from Astragali Radix in rat plasma by UHPLC-QTRAP-MS/MS.

  2024cites this paper
• Chemical Profile and Potential Application of Agri‐food Waste Products for Counteracting Diabetes Induced Neuropathy in Rats

  2024cites this paper
• Activation of Cryptic Donor Splice Sites within the UDP-Glucuronosyltransferase (UGT)1A First-Exon Region Generates Variant Transcripts That Encode UGT1A Proteins with Truncated Aglycone-Binding Domains

  2024cites this paper
• Luteolin: A promising natural agent in management of pain in chronic conditions

  2023cites this paper
• The potential biological effects of quercetin based on pharmacokinetics and multi-targeted mechanism in vivo

  2022cites this paper
• The Effects and Mechanisms of Flavonoids on Cancer Prevention and Therapy: Focus on Gut Microbiota

  2022cites this paper
• Hepatoenteric recycling is a new disposition mechanism for orally administered phenolic drugs and phytochemicals in rats

  2021cites this paper
• Developing nutritional component chrysin as a therapeutic agent: Bioavailability and pharmacokinetics consideration, and ADME mechanisms

  2021cites this paper
• Isoflavones derived from plant raw materials: bioavailability, anti-cancer, anti-aging potentials, and microbiome modulation

  2021cites this paper
• Does Oral Apigenin Have Real Potential for a Therapeutic Effect in the Context of Human Gastrointestinal and Other Cancers?

  2021cites this paper
• Development and validation of an LC-MS/MS method for the quantification of flavonoid glucuronides (wogonoside, baicalin, and apigenin-glucuronide) in the bile and blood samples: application to a portal vein infusion study.

  2020cites this paper
• Irinotecan-mediated diarrhea is mainly correlated with intestinal exposure to SN-38: Critical role of gut Ugt.

  2020cites this paper
• Cancer Chemoprevention by Flavonoids, Dietary Polyphenols and Terpenoids

  2020cites this paper
• Rapid intestinal glucuronidation and hepatic glucuronide recycling contributes significantly to the enterohepatic circulation of icaritin and its glucuronides in vivo

  2020cites this paper
• Validation of soy isoflavone intake and its health effects: a review of the development of exposure biomarkers

  2020cites this paper
• Targeting flavonoids on modulation of metabolic syndrome

  2020cites this paper
• Pharmacokinetics of B-Ring Unsubstituted Flavones

  2019cites this paper
• Formononetin: A Review of Its Anticancer Potentials and Mechanisms

  2019cites this paper
• Enterohepatic Circulation and Pharmacokinetics of Genistin and Genistein in Rats

  2019cites this paper
• Neuroprotective effects of flavonoid compounds on neuronal death associated to Alzheimer`s disease.

  2019cites this paper
• Anthocyanins and Their C6-C3-C6 Metabolites in Humans and Animals

  2019cites this paper
• Plasma quercetin metabolites are affected by intestinal microbiota of human microbiota-associated mice fed with a quercetin-containing diet

  2019cites this paper
• Cellular and molecular alterations induced by low-dose fisetin in human chronic myeloid leukemia cells

  2019cites this paper
• Absorption and Metabolism of Luteolin in Rats and Humans in Relation to in Vitro Anti-inflammatory Effects.

  2018cites this paper
• Chrysin attenuates testosterone-induced benign prostate hyperplasia in rats.

  2018cites this paper
• Chemical and Absorption Signatures of Xiao Chai Hu Tang.

  2018cites this paper
• Bioactive flavonoids in Moringa oleifera and their health-promoting properties

  2018cites this paper
• Intestinal disposition of quercetin and its phase‐II metabolites after oral administration in healthy volunteers

  2018cites this paper
• Influence of green tea consumption on cigarette smoking-induced biochemical changes in plasma and blood

  2017cites this paper
• Human anthocyanin bioavailability: effect of intake duration and dosing.

  2017cites this paper
• Cancer chemoprevention through dietary flavonoids: what’s limiting?

  2017cites this paper
• Glucuronidation: driving factors and their impact on glucuronide disposition

  2017cites this paper
• Transport-Glucuronidation Classification System and PBPK Modeling: New Approach To Predict the Impact of Transporters on Disposition of Glucuronides.

  2017cites this paper
• Influence of Intestinal Microbiota on the Catabolism of Flavonoids in Mice.

  2016cites this paper
• Challenges and Opportunities with Predicting In Vivo Phase II Metabolism via Glucuronidation From In Vitro Data

  2016cites this paper